Evaluation of the risk factors for BK virus-associated hemorrhagic cystitis in pediatric bone marrow transplantation patients: Does post-transplantation cyclophosphamide increase the frequency?

Gizem Zengin ErsoyCeyhun BozkurtBasak Adakli AksoyÖzlem Başoğlu ÖnerSelime AydoğduFunda ÇipeMurat SütçüOzan ÖzkayaTunç Fışgın

Published in: Pediatric transplantation (2022)

BKV-HC is an essential complication of HSCT primarily associated with Cy use, the presence of aGVHD, and donor relatedness. The present study shows that the use of Cy in the post-transplantation period further increases BKV-HC risk in pediatric patients, regardless of dose.

Keyphrases

bone marrow
end stage renal disease
ejection fraction
newly diagnosed
cell therapy
low dose
peritoneal dialysis
high dose
young adults